A potential disruptive technology in vaccine development: Gene-based vaccines and their application to infectious diseases

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 10, 2004, Pages 593-601

  Kaslow, David C ^a  

^a VICAL INC   (United States)

Author keywords

Disruptive technology; Efficacy threshold; Performance criteria; Plasmid DNA; Technology development; Vaccine development

Indexed keywords

ALPHA INTERFERON; ANGIOGENIC FACTOR; ANTHRAX VACCINE; BACTERIAL VACCINE; CHICKENPOX VACCINE; DIPHTHERIA TOXOID; DNA VACCINE; ERYTHROPOIETIN; GROWTH HORMONE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INSULIN; INTERLEUKIN 12; INTERLEUKIN 2; LIVE VACCINE; MEASLES VACCINE; MUMPS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PLASMID DNA; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; SMALL INTERFERING RNA; TETANUS TOXOID; TUMOR VACCINE; UNINDEXED DRUG; VIRUS VACCINE;

ARTICLE; BACTERIAL INFECTION; CANCER IMMUNOTHERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESEARCH; DRUG SYNTHESIS; GENE TECHNOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; MALARIA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; TUBERCULOSIS; VIRUS INFECTION;

COMMUNICABLE DISEASE CONTROL; DRUG DESIGN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; PLASMIDS; TECHNOLOGY, PHARMACEUTICAL; VACCINES, DNA;

BACTERIA (MICROORGANISMS);

EID: 5144221446     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2004.03.007     Document Type: Article

References (15)

1. Christensen C.M. 1997. The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail. Harvard Business School Press, Boston, Massachusetts.
2. Corbeil S. Lapatra S.E. Anderson E.D. Jones J. Vincent B. Hsu Y.L. Kurath G. Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout oncorhynchus mykiss using DNA vaccines Dis. Aquat. Organ. 39 1999 29-36
3. Esser M.T. Marchese R.D. Kierstead L.S. Tussey L.G. Wang F. Chirmule N. Washabaugh M.W. Memory T cells and vaccines Vaccine 21 2003 419-430
4. Fire A. Xu S. Montgomery M.K. Kostas S.A. Driver S.E. Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806-811
5. Fischer L. Tronel J.P. Minke J. Barzu S. Baudu P. Audonnet J.C. Vaccination of puppies with a lipid-formulated plasmid vaccine protects against a severe canine distemper virus challenge Vaccine 21 2003a 1099-1102
6. Fischer L. Minke J. Dufay N. Baudu P. Audonnet J.C. Rabies DNA vaccine in the horse: strategies to improve serological responses Vaccine 21 2003b 4593-4596
7. Lodmell D.L. Ray N.B. Parnell M.J. Ewalt L.C. Hanlon C.A. Shaddock J.H. Sanderlin D.S. Rupprecht C.E. DNA immunization protects nonhuman primates against rabies virus Nat. Med. 4 1998 949-952
8. Mizuno T. Chou M.Y. Inouye M. A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA) Proc. Natl. Acad. Sci. USA 7 1984 1966-1970
9. Norman J.A. Hobart P. Manthorpe M. Felgner P. Wheeler C. Development of improved vectors for DNA-based immunization and other gene therapy applications Vaccine 15 1997 801-803
10. Rappuoli R. Miller H.I. Falkow S. Medicine. The intangible value of vaccination Science 297 2002 937-939
11. Riordan. M. Hoddeson L. 1997. Crystal Fire: The Invention of the Transistor and the Birth of the Information Age. W.W. Norton & Company, New York.
12. Stewart J.J. Allison P.N. Johnson R.S. Putting a price on biotechnology Nat. Biotechnol. 19 2001 813-817
13. Turell M.J. Bunning M. Ludwig G.V. Ortman B. Chang J. Speaker T. Spielman A. McLean R. Komar N. Gates R. McNamara T. Creekmore T. Farley L. Mitchell C.J. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus) Emerg. Infect. Dis. 9 2003 1077-1081
14. Wang R. Doolan D.L. Charoenvit Y. Hedstrom R.C. Gardner M.J. Hobart P. Tine J. Sedegah M. Fallarme V. Sacci J.B. Jr. Kaur M. Klinman D.M. Hoffman S.L. Weiss W.R. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids Infect. Immun. 66 1998 4193-4202
15. Wolters B. Junge U. Dziuba S. Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons Vaccine 21 2003 3623-3628